American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$234M |
| 2 |
Unilever
UL
|
+$230M |
| 3 |
Sysco
SYY
|
+$212M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$206M |
| 5 |
Sea Limited
SE
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$395M |
| 2 |
Boston Scientific
BSX
|
+$331M |
| 3 |
Illumina
ILMN
|
+$318M |
| 4 |
Alibaba
BABA
|
+$296M |
| 5 |
SBA Communications
SBAC
|
+$267M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.12% |
| 2 | Financials | 14.89% |
| 3 | Healthcare | 14.13% |
| 4 | Consumer Discretionary | 14.08% |
| 5 | Industrials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Vital Farms
VITL
$498M
| $15.4M | 0.01% |
606,570
+2,960
| +0.5% | +$93.5K |
|
677
Paylocity
PCTY
$8.1B
| $15.3M | 0.01% |
74,522
-531
| -0.7% | -$102K |
|
678
CSX Corp
CSX
$92.9B
| $15.3M | 0.01% |
506,382
+38,277
| +8% | +$1.1M |
|
679
Urban Edge Properties
UE
$2.78B
| $15.3M | 0.01% |
1,181,763
-187,331
| -14% | -$2.25M |
|
680
Arcosa
ACA
$7.12B
| $15.3M | 0.01% |
278,375
-141,075
| -34% | -$7.2M |
|
681
Graham Corp
GHM
$1.3B
| $14.9M | 0.01% |
979,405
+30,580
| +3% | +$449K |
|
682
Expeditors International
EXPD
$24.3B
| $14.8M | 0.01% |
155,865
+9,436
| +6% | +$860K |
|
683
Levi Strauss
LEVI
$8.63B
| $14.7M | 0.01% |
+733,079
| New | +$13.1M |
|
|
TCF
684
DELISTED
TCF Financial Corporation Common Stock
TCF
| $14.7M | 0.01% |
397,001
+193,452
| +95% | +$6.15M |
|
685
Caterpillar
CAT
$393B
| $14.6M | 0.01% |
80,280
-36,186
| -31% | -$6.14M |
|
686
National Healthcare
NHC
$3.44B
| $14.6M | 0.01% |
219,833
+58,363
| +36% | +$3.84M |
|
|
SPNS
687
DELISTED
Sapiens International
SPNS
| $14.6M | 0.01% |
476,851
+201,902
| +73% | +$5.92M |
|
688
SL Green Realty
SLG
$4.08B
| $14.6M | 0.01% |
237,997
-160,071
| -40% | -$8.47M |
|
|
XLRN
689
DELISTED
Acceleron Pharma
XLRN
| $14.3M | 0.01% |
111,979
-5,888
| -5% | -$690K |
|
690
Gen Digital
GEN
$17.7B
| $14.3M | 0.01% |
686,839
-1,433,955
| -68% | -$29M |
|
|
KRTX
691
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $14.3M | 0.01% |
140,376
+8,343
| +6% | +$773K |
|
692
Blackstone
BX
$112B
| $14.3M | 0.01% |
+220,001
| New | +$12.8M |
|
693
Lattice Semiconductor
LSCC
$18.2B
| $14.2M | 0.01% |
309,750
+1,689
| +0.5% | +$65.3K |
|
694
nLIGHT
LASR
$2.9B
| $14M | 0.01% |
429,362
+254,434
| +145% | +$7.21M |
|
695
Neurocrine Biosciences
NBIX
$15.3B
| $14M | 0.01% |
146,017
-56,578
| -28% | -$5.46M |
|
|
JBGS
696
JBG SMITH
JBGS
$692M
| $13.8M | 0.01% |
441,660
+57,417
| +15% | +$1.66M |
|
|
MRTX
697
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $13.7M | 0.01% |
62,401
-2,374
| -4% | -$513K |
|
698
IBEX
IBEX
$482M
| $13.7M | 0.01% |
732,358
+606,259
| +481% | +$10.8M |
|
|
EFOR
699
Everforth Inc
EFOR
$1.37B
| $13.7M | 0.01% |
163,796
-5,588
| -3% | -$430K |
|
700
Ceco Environmental
CECO
$4.5B
| $13.6M | 0.01% |
1,960,543
+93,337
| +5% | +$686K |
|
Similar funds
American Century Companies's Q4 2020 Portfolio in Review
As of Q4 2020, American Century Companies held 2,076 positions worth $128B, up 14% from $113B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
American Century Companies's Q4 2020 filing shows 276 new, 1,105 increased, 539 reduced and 122 closed positions. Its largest new stake was Crane NXT: 2,746,264 shares worth $74.1M. The largest sale was iShares Russell 1000 Value ETF, an estimated $395M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q4 2020 buy was Crane NXT: 2,746,264 shares worth $74.1M.
- American Century Companies added most to Colgate-Palmolive in Q4 2020, an estimated $234M increase.
- American Century Companies's biggest Q4 2020 reduction was iShares Russell 1000 Value ETF, cutting an estimated $395M.
- American Century Companies fully exited Wells Fargo 7.5% Non Cumv Perp Conv in Q4 2020, selling an estimated $154M.
- American Century Companies's ten largest holdings make up 22% of its $128B portfolio in Q4 2020.
- American Century Companies opened 276 new positions and closed 122 in Q4 2020.
- American Century Companies's portfolio value rose 14% quarter-over-quarter to $128B.
Based on American Century Companies's 13F filing for Q4 2020, filed 12 Feb 2021.